About UMEKIR PHARMA
UMEKIR PHARMA is a company based in Raigad (India) founded in 2016 by Sampada Shankar Naik and Sandhya Umesh Pal. It operates as a B2B. UMEKIR PHARMA offers products and services including Branded Products, Generics Products, Cardio-Vascular Products, and Injections. UMEKIR PHARMA operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Raigad, India
- Founders Sampada Shankar Naik, Sandhya Umesh Pal
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website umekirpharma.com
- Legal Name Umekir Pharma Pvt Ltd
- Date of Incorporation 09 Feb, 2016
- Jurisdiction Raigarh, Maharashtra, India
Associated legal entities of UMEKIR PHARMA
UMEKIR PHARMA operates through Umekir Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Umekir Pharma Private Limited CIN U24296MH2016PTC272934 | Active | 09 Feb 2016 | Raigarh, Maharashtra | – | – | 2 | View details |
Products & Services of UMEKIR PHARMA
UMEKIR PHARMA offers a comprehensive portfolio of products and services, including Branded Products, Generics Products, Cardio-Vascular Products, and Injections.
High-quality branded medicines for various therapy segments
Affordable generic drugs for essential health needs
Medications targeting cardiovascular conditions and treatments
Injectable forms for immediate and targeted medical applications
Board of directors of Umekir Pharma Private Limited (UMEKIR PHARMA)
Umekir Pharma Private Limited is the primary company behind UMEKIR PHARMA. The board of Umekir Pharma Private Limited currently have 2 directors; the longest-serving is Sandhya Umesh Pal, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandhya Umesh Pal DIN 07431670 | Director | 09 Feb 2016 | 10 yrs 8 mo | Umekir Pharma Private Limited |
| Sampada Shankar Naik DIN 07427184 | Director | 09 Feb 2016 | 10 yrs 8 mo | Umekir Pharma Private Limited |
People of UMEKIR PHARMA
2 people are tracked at UMEKIR PHARMA (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Director | Leadership | |
| Co-Founder, Director | Leadership |
Complete people profiles for UMEKIR PHARMA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of UMEKIR PHARMA
UMEKIR PHARMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of UMEKIR PHARMA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to UMEKIR PHARMA
10 companies that operate in the same segment as UMEKIR PHARMA (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about UMEKIR PHARMA
UMEKIR PHARMA was founded in 2016.
UMEKIR PHARMA is headquartered in Raigad, India. It is registered at Raigad, Maharashtra, India.
UMEKIR PHARMA is a WHO-GMP certified pharmaceutical manufacturer based in India, producing branded, generics, cardio-vascular, and injection products. The company focuses on delivering high-quality medicines at affordable prices through a strong distribution network. It operates with international standards and has approvals from countries like Uganda, Ghana, Nigeria, and Kenya. Their activities include manufacturing and marketing across various therapy segments to support global health.
UMEKIR PHARMA's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
UMEKIR PHARMA offers Branded Products, Generics Products, Cardio-Vascular Products, and Injections.
UMEKIR PHARMA operates through Umekir Pharma Private Limited.
The legal entities of UMEKIR PHARMA currently have 2 directors, including Sandhya Umesh Pal, Sampada Shankar Naik.